Oxford Lane Capital delivers growth with record investments, though dilution affects NII per share. Read why OXLC is at a 6% ...
Cipla, one of India's largest drugmaker by sales, reported a bigger-than-expected third-quarter profit on Tuesday, helped by ...
Revenue decreased by 1.03% YoY & profit decreased by 17.05% YoY, profit at ₹8505.57 crore and revenue at ₹35779.78 crore ...
In addition to the internal combustion A6-replacing A7 family, the Audi brand has a brand-new Q3 family in store for 2025 as ...
Earnings before interest, depreciation and amortisation (EBITDA) for Nandan dropped 8.42% to Rs 30.87 crore from the previous ...
Suzlon Q3 net profit is estimated to see a high double-digit growth on YoY basis, as well as sequentially. The company’s ...
In the corresponding quarter of the previous fiscal, Piramal Pharma posted a net profit of ₹10.1 crore, the company said in a ...
Arvind’s textile division reported an 11% revenue growth of Rs 1,577 crore with an EBITDA of Rs 177 crore, translating to a ...